Literature DB >> 14751754

Process development of an acellular dermal matrix (ADM) for biomedical applications.

Ray-Neng Chen1, Hsiu-O Ho, Yu-Ting Tsai, Ming-Thau Sheu.   

Abstract

The object of this study was to compare the extent of decellularization at each critical step of processing porcine skin to produce an acellular dermal matrix (ADM) for biomedical applications. The results demonstrated that the removal of epidermis using treatment with 0.25% trypsin for 18 h and 0.1% sodium dodecyl sulfate (SDS) for 12 h at room temperature was beneficial for the subsequent treatment to remove cells in the dermal structure. Lengthy incubation in 0.25% trypsin (12 h) and then 560 units/l Dispase (12 h) at 25 degrees C of small pieces of porcine skin from which the epidermis had been removed efficiently removed cells and cellular components from the skin. Histological examinations revealed that the epidermis, dermal fibroblasts, and epidermal appendages were completely removed by these treatments, and the basic dermal architecture of collagen bundles was that of a loose meshwork. Examinations by TEM showed that the characteristics of collagen fibers in the ADM were retained after complete removal of cells present under optimal conditions defined in this study. SDS-PAGE and size-exclusion HPLC revealed that collagen fibers in the ADM were mostly type I and showed two typical component peaks identified as oligomers and monomers, respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751754     DOI: 10.1016/j.biomaterials.2003.09.070

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  52 in total

Review 1.  State of the art in burn treatment.

Authors:  Bishara S Atiyeh; S William Gunn; Shady N Hayek
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

2.  Mechanical and failure properties of extracellular matrix sheets as a function of structural protein composition.

Authors:  Lauren D Black; Philip G Allen; Shirley M Morris; Phillip J Stone; Béla Suki
Journal:  Biophys J       Date:  2007-11-09       Impact factor: 4.033

3.  Novel utilization of serum in tissue decellularization.

Authors:  Liqiong Gui; Stephen A Chan; Christopher K Breuer; Laura E Niklason
Journal:  Tissue Eng Part C Methods       Date:  2010-04       Impact factor: 3.056

4.  [Appllication of human acellular dermal matrix in surgical treatment of genitourinary disease].

Authors:  Z C Xin; B C Yang; M Li; Y M Yuan; W S Cui; Y Tang; D Fang; W D Song
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

5.  [Complications and management for penile augmentation with acellular dermal matrix].

Authors:  T M Xu; X W Zhang; G X Zhang; W J Bai; Q Li; T Xu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

6.  A novel technique for simultaneous whole-body and multi-organ decellularization: umbilical artery catheterization as a perfusion-based method in a sheep foetus model.

Authors:  Abdol-Mohammad Kajbafzadeh; Reza Khorramirouz; Aram Akbarzadeh; Shabnam Sabetkish; Nastaran Sabetkish; Paria Saadat; Mona Tehrani
Journal:  Int J Exp Pathol       Date:  2015-04       Impact factor: 1.925

7.  A preliminary study on the development of a novel biomatrix by decellularization of bovine spinal meninges for tissue engineering applications.

Authors:  Eren Ozudogru; Yavuz Emre Arslan
Journal:  Cell Tissue Bank       Date:  2020-08-30       Impact factor: 1.522

Review 8.  Engineering hydrogels as extracellular matrix mimics.

Authors:  Hikmet Geckil; Feng Xu; Xiaohui Zhang; SangJun Moon; Utkan Demirci
Journal:  Nanomedicine (Lond)       Date:  2010-04       Impact factor: 5.307

9.  Decellularization of bovine anterior cruciate ligament tissues minimizes immunogenic reactions to alpha-gal epitopes by human peripheral blood mononuclear cells.

Authors:  Ryu Yoshida; Patrick Vavken; Martha M Murray
Journal:  Knee       Date:  2011-09-16       Impact factor: 2.199

10.  Acellularization of embryoid bodies via physical disruption methods.

Authors:  Alyssa V Ngangan; Todd C McDevitt
Journal:  Biomaterials       Date:  2008-11-29       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.